Global Pneumococcal Bacteria Vaccine Market Insights and Forecast to 2028

Global Pneumococcal Bacteria Vaccine Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Pneumococcal Bacteria Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 PPSV 23
1.2.3 PCV 13
1.2.4 PCV 10
1.3 Market by Application
1.3.1 Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Infant
1.3.3 Children
1.3.4 Adult
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pneumococcal Bacteria Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Pneumococcal Bacteria Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Pneumococcal Bacteria Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pneumococcal Bacteria Vaccine Sales by Region
2.4.1 Global Pneumococcal Bacteria Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Pneumococcal Bacteria Vaccine by Region (2023-2028)
2.5 Global Pneumococcal Bacteria Vaccine Revenue by Region
2.5.1 Global Pneumococcal Bacteria Vaccine Revenue by Region (2017-2022)
2.5.2 Global Pneumococcal Bacteria Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pneumococcal Bacteria Vaccine Sales by Manufacturers
3.1.1 Global Top Pneumococcal Bacteria Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Pneumococcal Bacteria Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pneumococcal Bacteria Vaccine in 2021
3.2 Global Pneumococcal Bacteria Vaccine Revenue by Manufacturers
3.2.1 Global Pneumococcal Bacteria Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pneumococcal Bacteria Vaccine Revenue in 2021
3.3 Global Pneumococcal Bacteria Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pneumococcal Bacteria Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pneumococcal Bacteria Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pneumococcal Bacteria Vaccine Sales by Type
4.1.1 Global Pneumococcal Bacteria Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Pneumococcal Bacteria Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Pneumococcal Bacteria Vaccine Revenue by Type
4.2.1 Global Pneumococcal Bacteria Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Pneumococcal Bacteria Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Pneumococcal Bacteria Vaccine Price by Type
4.3.1 Global Pneumococcal Bacteria Vaccine Price by Type (2017-2022)
4.3.2 Global Pneumococcal Bacteria Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pneumococcal Bacteria Vaccine Sales by Application
5.1.1 Global Pneumococcal Bacteria Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Pneumococcal Bacteria Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Pneumococcal Bacteria Vaccine Revenue by Application
5.2.1 Global Pneumococcal Bacteria Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Pneumococcal Bacteria Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Pneumococcal Bacteria Vaccine Price by Application
5.3.1 Global Pneumococcal Bacteria Vaccine Price by Application (2017-2022)
5.3.2 Global Pneumococcal Bacteria Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pneumococcal Bacteria Vaccine Market Size by Type
6.1.1 North America Pneumococcal Bacteria Vaccine Sales by Type (2017-2028)
6.1.2 North America Pneumococcal Bacteria Vaccine Revenue by Type (2017-2028)
6.2 North America Pneumococcal Bacteria Vaccine Market Size by Application
6.2.1 North America Pneumococcal Bacteria Vaccine Sales by Application (2017-2028)
6.2.2 North America Pneumococcal Bacteria Vaccine Revenue by Application (2017-2028)
6.3 North America Pneumococcal Bacteria Vaccine Market Size by Country
6.3.1 North America Pneumococcal Bacteria Vaccine Sales by Country (2017-2028)
6.3.2 North America Pneumococcal Bacteria Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Pneumococcal Bacteria Vaccine Market Size by Type
7.1.1 Europe Pneumococcal Bacteria Vaccine Sales by Type (2017-2028)
7.1.2 Europe Pneumococcal Bacteria Vaccine Revenue by Type (2017-2028)
7.2 Europe Pneumococcal Bacteria Vaccine Market Size by Application
7.2.1 Europe Pneumococcal Bacteria Vaccine Sales by Application (2017-2028)
7.2.2 Europe Pneumococcal Bacteria Vaccine Revenue by Application (2017-2028)
7.3 Europe Pneumococcal Bacteria Vaccine Market Size by Country
7.3.1 Europe Pneumococcal Bacteria Vaccine Sales by Country (2017-2028)
7.3.2 Europe Pneumococcal Bacteria Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pneumococcal Bacteria Vaccine Market Size by Type
8.1.1 Asia Pacific Pneumococcal Bacteria Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Pneumococcal Bacteria Vaccine Market Size by Application
8.2.1 Asia Pacific Pneumococcal Bacteria Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Pneumococcal Bacteria Vaccine Market Size by Region
8.3.1 Asia Pacific Pneumococcal Bacteria Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Pneumococcal Bacteria Vaccine Market Size by Type
9.1.1 Latin America Pneumococcal Bacteria Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Pneumococcal Bacteria Vaccine Revenue by Type (2017-2028)
9.2 Latin America Pneumococcal Bacteria Vaccine Market Size by Application
9.2.1 Latin America Pneumococcal Bacteria Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Pneumococcal Bacteria Vaccine Revenue by Application (2017-2028)
9.3 Latin America Pneumococcal Bacteria Vaccine Market Size by Country
9.3.1 Latin America Pneumococcal Bacteria Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Pneumococcal Bacteria Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pneumococcal Bacteria Vaccine Market Size by Type
10.1.1 Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Pneumococcal Bacteria Vaccine Market Size by Application
10.2.1 Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Pneumococcal Bacteria Vaccine Market Size by Country
10.3.1 Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Recent Developments
11.3 Sinopharm
11.3.1 Sinopharm Corporation Information
11.3.2 Sinopharm Overview
11.3.3 Sinopharm Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sinopharm Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sinopharm Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Walvax
11.5.1 Walvax Corporation Information
11.5.2 Walvax Overview
11.5.3 Walvax Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Walvax Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Walvax Recent Developments
11.6 GSK
11.6.1 GSK Corporation Information
11.6.2 GSK Overview
11.6.3 GSK Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 GSK Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GSK Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pneumococcal Bacteria Vaccine Industry Chain Analysis
12.2 Pneumococcal Bacteria Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pneumococcal Bacteria Vaccine Production Mode & Process
12.4 Pneumococcal Bacteria Vaccine Sales and Marketing
12.4.1 Pneumococcal Bacteria Vaccine Sales Channels
12.4.2 Pneumococcal Bacteria Vaccine Distributors
12.5 Pneumococcal Bacteria Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pneumococcal Bacteria Vaccine Industry Trends
13.2 Pneumococcal Bacteria Vaccine Market Drivers
13.3 Pneumococcal Bacteria Vaccine Market Challenges
13.4 Pneumococcal Bacteria Vaccine Market Restraints
14 Key Findings in The Global Pneumococcal Bacteria Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of PPSV 23
Table 3. Major Manufacturers of PCV 13
Table 4. Major Manufacturers of PCV 10
Table 5. Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Pneumococcal Bacteria Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Pneumococcal Bacteria Vaccine Sales by Region (2017-2022) & (K Units)
Table 8. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2017-2022)
Table 9. Global Pneumococcal Bacteria Vaccine Sales by Region (2023-2028) & (K Units)
Table 10. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2023-2028)
Table 11. Global Pneumococcal Bacteria Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2017-2022)
Table 13. Global Pneumococcal Bacteria Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2023-2028)
Table 15. Global Pneumococcal Bacteria Vaccine Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Pneumococcal Bacteria Vaccine Sales Share by Manufacturers (2017-2022)
Table 17. Global Pneumococcal Bacteria Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Pneumococcal Bacteria Vaccine Revenue Share by Manufacturers (2017-2022)
Table 19. Pneumococcal Bacteria Vaccine Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Pneumococcal Bacteria Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Pneumococcal Bacteria Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Bacteria Vaccine as of 2021)
Table 22. Pneumococcal Bacteria Vaccine Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Pneumococcal Bacteria Vaccine Product Offered
Table 24. Date of Manufacturers Enter into Pneumococcal Bacteria Vaccine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pneumococcal Bacteria Vaccine Sales by Type (2017-2022) & (K Units)
Table 27. Global Pneumococcal Bacteria Vaccine Sales by Type (2023-2028) & (K Units)
Table 28. Global Pneumococcal Bacteria Vaccine Sales Share by Type (2017-2022)
Table 29. Global Pneumococcal Bacteria Vaccine Sales Share by Type (2023-2028)
Table 30. Global Pneumococcal Bacteria Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Pneumococcal Bacteria Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Pneumococcal Bacteria Vaccine Revenue Share by Type (2017-2022)
Table 33. Global Pneumococcal Bacteria Vaccine Revenue Share by Type (2023-2028)
Table 34. Pneumococcal Bacteria Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Pneumococcal Bacteria Vaccine Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Pneumococcal Bacteria Vaccine Sales by Application (2017-2022) & (K Units)
Table 37. Global Pneumococcal Bacteria Vaccine Sales by Application (2023-2028) & (K Units)
Table 38. Global Pneumococcal Bacteria Vaccine Sales Share by Application (2017-2022)
Table 39. Global Pneumococcal Bacteria Vaccine Sales Share by Application (2023-2028)
Table 40. Global Pneumococcal Bacteria Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Pneumococcal Bacteria Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Pneumococcal Bacteria Vaccine Revenue Share by Application (2017-2022)
Table 43. Global Pneumococcal Bacteria Vaccine Revenue Share by Application (2023-2028)
Table 44. Pneumococcal Bacteria Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Pneumococcal Bacteria Vaccine Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Pneumococcal Bacteria Vaccine Sales by Type (2017-2022) & (K Units)
Table 47. North America Pneumococcal Bacteria Vaccine Sales by Type (2023-2028) & (K Units)
Table 48. North America Pneumococcal Bacteria Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Pneumococcal Bacteria Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Pneumococcal Bacteria Vaccine Sales by Application (2017-2022) & (K Units)
Table 51. North America Pneumococcal Bacteria Vaccine Sales by Application (2023-2028) & (K Units)
Table 52. North America Pneumococcal Bacteria Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Pneumococcal Bacteria Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Pneumococcal Bacteria Vaccine Sales by Country (2017-2022) & (K Units)
Table 55. North America Pneumococcal Bacteria Vaccine Sales by Country (2023-2028) & (K Units)
Table 56. North America Pneumococcal Bacteria Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Pneumococcal Bacteria Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Pneumococcal Bacteria Vaccine Sales by Type (2017-2022) & (K Units)
Table 59. Europe Pneumococcal Bacteria Vaccine Sales by Type (2023-2028) & (K Units)
Table 60. Europe Pneumococcal Bacteria Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Pneumococcal Bacteria Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Pneumococcal Bacteria Vaccine Sales by Application (2017-2022) & (K Units)
Table 63. Europe Pneumococcal Bacteria Vaccine Sales by Application (2023-2028) & (K Units)
Table 64. Europe Pneumococcal Bacteria Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Pneumococcal Bacteria Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Pneumococcal Bacteria Vaccine Sales by Country (2017-2022) & (K Units)
Table 67. Europe Pneumococcal Bacteria Vaccine Sales by Country (2023-2028) & (K Units)
Table 68. Europe Pneumococcal Bacteria Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Pneumococcal Bacteria Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Pneumococcal Bacteria Vaccine Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Pneumococcal Bacteria Vaccine Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Pneumococcal Bacteria Vaccine Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Pneumococcal Bacteria Vaccine Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Pneumococcal Bacteria Vaccine Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Pneumococcal Bacteria Vaccine Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Pneumococcal Bacteria Vaccine Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Pneumococcal Bacteria Vaccine Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Pneumococcal Bacteria Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Pneumococcal Bacteria Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Pneumococcal Bacteria Vaccine Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Pneumococcal Bacteria Vaccine Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Pneumococcal Bacteria Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Pneumococcal Bacteria Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Pneumococcal Bacteria Vaccine Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Pneumococcal Bacteria Vaccine Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Pneumococcal Bacteria Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Pneumococcal Bacteria Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 106. Merck Corporation Information
Table 107. Merck Description and Major Businesses
Table 108. Merck Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Merck Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Merck Recent Developments
Table 111. Sanofi Corporation Information
Table 112. Sanofi Description and Major Businesses
Table 113. Sanofi Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. Sanofi Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Sanofi Recent Developments
Table 116. Sinopharm Corporation Information
Table 117. Sinopharm Description and Major Businesses
Table 118. Sinopharm Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Sinopharm Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Sinopharm Recent Developments
Table 121. Pfizer Corporation Information
Table 122. Pfizer Description and Major Businesses
Table 123. Pfizer Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Pfizer Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Pfizer Recent Developments
Table 126. Walvax Corporation Information
Table 127. Walvax Description and Major Businesses
Table 128. Walvax Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Walvax Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Walvax Recent Developments
Table 131. GSK Corporation Information
Table 132. GSK Description and Major Businesses
Table 133. GSK Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. GSK Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. GSK Recent Developments
Table 136. Key Raw Materials Lists
Table 137. Raw Materials Key Suppliers Lists
Table 138. Pneumococcal Bacteria Vaccine Distributors List
Table 139. Pneumococcal Bacteria Vaccine Customers List
Table 140. Pneumococcal Bacteria Vaccine Market Trends
Table 141. Pneumococcal Bacteria Vaccine Market Drivers
Table 142. Pneumococcal Bacteria Vaccine Market Challenges
Table 143. Pneumococcal Bacteria Vaccine Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Pneumococcal Bacteria Vaccine Product Picture
Figure 3. Global Pneumococcal Bacteria Vaccine Market Share by Type in 2021 & 2028
Figure 3. PPSV 23 Product Picture
Figure 4. PCV 13 Product Picture
Figure 5. PCV 10 Product Picture
Figure 6. Global Pneumococcal Bacteria Vaccine Market Share by Application in 2021 & 2028
Figure 7. Infant
Figure 8. Children
Figure 9. Adult
Figure 10. Pneumococcal Bacteria Vaccine Report Years Considered
Figure 11. Global Pneumococcal Bacteria Vaccine Sales 2017-2028 (K Units)
Figure 12. Global Pneumococcal Bacteria Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Pneumococcal Bacteria Vaccine Revenue 2017-2028 (US$ Million)
Figure 14. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2017-2022)
Figure 16. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2023-2028)
Figure 17. North America Pneumococcal Bacteria Vaccine Sales YoY (2017-2028) & (K Units)
Figure 18. North America Pneumococcal Bacteria Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Pneumococcal Bacteria Vaccine Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Pneumococcal Bacteria Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Pneumococcal Bacteria Vaccine Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Pneumococcal Bacteria Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Pneumococcal Bacteria Vaccine Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Pneumococcal Bacteria Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Pneumococcal Bacteria Vaccine Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Pneumococcal Bacteria Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Pneumococcal Bacteria Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Pneumococcal Bacteria Vaccine in the World: Market Share by Pneumococcal Bacteria Vaccine Revenue in 2021
Figure 29. Global Pneumococcal Bacteria Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2017-2028)
Figure 31. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2017-2028)
Figure 32. Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2017-2028)
Figure 33. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2017-2028)
Figure 34. North America Pneumococcal Bacteria Vaccine Sales Market Share by Type (2017-2028)
Figure 35. North America Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2017-2028)
Figure 36. North America Pneumococcal Bacteria Vaccine Sales Market Share by Application (2017-2028)
Figure 37. North America Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2017-2028)
Figure 38. North America Pneumococcal Bacteria Vaccine Sales Share by Country (2017-2028)
Figure 39. North America Pneumococcal Bacteria Vaccine Revenue Share by Country (2017-2028)
Figure 40. U.S. Pneumococcal Bacteria Vaccine Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Pneumococcal Bacteria Vaccine Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Type (2017-2028)
Figure 43. Europe Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2017-2028)
Figure 44. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Application (2017-2028)
Figure 45. Europe Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2017-2028)
Figure 46. Europe Pneumococcal Bacteria Vaccine Sales Share by Country (2017-2028)
Figure 47. Europe Pneumococcal Bacteria Vaccine Revenue Share by Country (2017-2028)
Figure 48. Germany Pneumococcal Bacteria Vaccine Revenue (2017-2028) & (US$ Million)
Figure 49. France Pneumococcal Bacteria Vaccine Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Pneumococcal Bacteria Vaccine Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Pneumococcal Bacteria Vaccine Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Pneumococcal Bacteria Vaccine Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Pneumococcal Bacteria Vaccine Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Pneumococcal Bacteria Vaccine Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Pneumococcal Bacteria Vaccine Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Pneumococcal Bacteria Vaccine Revenue Share by Region (2017-2028)
Figure 59. China Pneumococcal Bacteria Vaccine Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Pneumococcal Bacteria Vaccine Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Pneumococcal Bacteria Vaccine Revenue (2017-2028) & (US$ Million)
Figure 62. India Pneumococcal Bacteria Vaccine Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Pneumococcal Bacteria Vaccine Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Pneumococcal Bacteria Vaccine Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Pneumococcal Bacteria Vaccine Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Pneumococcal Bacteria Vaccine Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Pneumococcal Bacteria Vaccine Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Pneumococcal Bacteria Vaccine Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Pneumococcal Bacteria Vaccine Sales Market Share by Type (2017-2028)
Figure 70. Latin America Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Pneumococcal Bacteria Vaccine Sales Market Share by Application (2017-2028)
Figure 72. Latin America Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Pneumococcal Bacteria Vaccine Sales Share by Country (2017-2028)
Figure 74. Latin America Pneumococcal Bacteria Vaccine Revenue Share by Country (2017-2028)
Figure 75. Mexico Pneumococcal Bacteria Vaccine Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Pneumococcal Bacteria Vaccine Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Pneumococcal Bacteria Vaccine Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Pneumococcal Bacteria Vaccine Sales Market Shar

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs